カテゴリー： QYResearch, 世界

世界のパーキンソン病薬市場 2019年

【英語タイトル】Global Parkinson's Disease Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X12634）・商品コード：DATA909X12634
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：115
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、パーキンソン病薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、シネメット-CR、トラスター、マドパル、COMT阻害剤、その他に、用途別には、40歳未満、40-65歳、65歳以上にセグメント区分し、パーキンソン病薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・パーキンソン病薬の世界市場概要
・パーキンソン病薬の製造コスト構成分析
・パーキンソン病薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・パーキンソン病薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・パーキンソン病薬のセグメント分析（種類別）
（シネメット-CR、トラスター、マドパル、COMT阻害剤、その他）
・パーキンソン病薬のセグメント分析（用途別）
（40歳未満、40-65歳、65歳以上）
・パーキンソン病薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Merck、Akorn、GSK、Novartis、Boehringer Ingelheim、Teva Pharmaceutical、Abbvie、Kyowa Hakko Kirin Pharma、Astellas Pharma、Desitin Arzneimittel、Endo Pharmaceuticals、F.Hoffmann-La Roche、H.Lundbeck、Valeant、Apokyn、Orion、Stada Arzneimittel、US WorldMeds、Valeant Pharmaceuticals、）
・パーキンソン病薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Parkinson’s Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Parkinson’s Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Parkinson’s Disease Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Parkinson’s Disease Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Parkinson’s Disease Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Valeant Pharmaceuticals

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other

Segment by Application
Under 40 Years Old
40-65 Years Old
Above 65 Years Old

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Parkinson’s Disease Drug
1.1 Definition of Parkinson’s Disease Drug
1.2 Parkinson’s Disease Drug Segment by Type
1.2.1 Global Parkinson’s Disease Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Sinemet-CR
1.2.3 Trastal
1.2.4 Madopar
1.2.5 COMT Inhibitor
1.2.6 Other
1.3 Parkinson’s Disease Drug Segment by Applications
1.3.1 Global Parkinson’s Disease Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Global Parkinson’s Disease Drug Overall Market
1.4.1 Global Parkinson’s Disease Drug Revenue (2014-2025)
1.4.2 Global Parkinson’s Disease Drug Production (2014-2025)
1.4.3 North America Parkinson’s Disease Drug Status and Prospect (2014-2025)
1.4.4 Europe Parkinson’s Disease Drug Status and Prospect (2014-2025)
1.4.5 China Parkinson’s Disease Drug Status and Prospect (2014-2025)
1.4.6 Japan Parkinson’s Disease Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Parkinson’s Disease Drug Status and Prospect (2014-2025)
1.4.8 India Parkinson’s Disease Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Parkinson’s Disease Drug
2.3 Manufacturing Process Analysis of Parkinson’s Disease Drug
2.4 Industry Chain Structure of Parkinson’s Disease Drug

3 Development and Manufacturing Plants Analysis of Parkinson’s Disease Drug
3.1 Capacity and Commercial Production Date
3.2 Global Parkinson’s Disease Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Parkinson’s Disease Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Parkinson’s Disease Drug Production and Capacity Analysis
4.2 Parkinson’s Disease Drug Revenue Analysis
4.3 Parkinson’s Disease Drug Price Analysis
4.4 Market Concentration Degree

5 Parkinson’s Disease Drug Regional Market Analysis
5.1 Parkinson’s Disease Drug Production by Regions
5.1.1 Global Parkinson’s Disease Drug Production by Regions
5.1.2 Global Parkinson’s Disease Drug Revenue by Regions
5.2 Parkinson’s Disease Drug Consumption by Regions
5.3 North America Parkinson’s Disease Drug Market Analysis
5.3.1 North America Parkinson’s Disease Drug Production
5.3.2 North America Parkinson’s Disease Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Parkinson’s Disease Drug Import and Export
5.4 Europe Parkinson’s Disease Drug Market Analysis
5.4.1 Europe Parkinson’s Disease Drug Production
5.4.2 Europe Parkinson’s Disease Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Parkinson’s Disease Drug Import and Export
5.5 China Parkinson’s Disease Drug Market Analysis
5.5.1 China Parkinson’s Disease Drug Production
5.5.2 China Parkinson’s Disease Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Parkinson’s Disease Drug Import and Export
5.6 Japan Parkinson’s Disease Drug Market Analysis
5.6.1 Japan Parkinson’s Disease Drug Production
5.6.2 Japan Parkinson’s Disease Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Parkinson’s Disease Drug Import and Export
5.7 Southeast Asia Parkinson’s Disease Drug Market Analysis
5.7.1 Southeast Asia Parkinson’s Disease Drug Production
5.7.2 Southeast Asia Parkinson’s Disease Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Parkinson’s Disease Drug Import and Export
5.8 India Parkinson’s Disease Drug Market Analysis
5.8.1 India Parkinson’s Disease Drug Production
5.8.2 India Parkinson’s Disease Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Parkinson’s Disease Drug Import and Export

6 Parkinson’s Disease Drug Segment Market Analysis (by Type)
6.1 Global Parkinson’s Disease Drug Production by Type
6.2 Global Parkinson’s Disease Drug Revenue by Type
6.3 Parkinson’s Disease Drug Price by Type

7 Parkinson’s Disease Drug Segment Market Analysis (by Application)
7.1 Global Parkinson’s Disease Drug Consumption by Application
7.2 Global Parkinson’s Disease Drug Consumption Market Share by Application (2014-2019)

8 Parkinson’s Disease Drug Major Manufacturers Analysis
8.1 Merck
8.1.1 Merck Parkinson’s Disease Drug Production Sites and Area Served
8.1.2 Merck Product Introduction, Application and Specification
8.1.3 Merck Parkinson’s Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Akorn
8.2.1 Akorn Parkinson’s Disease Drug Production Sites and Area Served
8.2.2 Akorn Product Introduction, Application and Specification
8.2.3 Akorn Parkinson’s Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 GSK
8.3.1 GSK Parkinson’s Disease Drug Production Sites and Area Served
8.3.2 GSK Product Introduction, Application and Specification
8.3.3 GSK Parkinson’s Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Novartis
8.4.1 Novartis Parkinson’s Disease Drug Production Sites and Area Served
8.4.2 Novartis Product Introduction, Application and Specification
8.4.3 Novartis Parkinson’s Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Boehringer Ingelheim
8.5.1 Boehringer Ingelheim Parkinson’s Disease Drug Production Sites and Area Served
8.5.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.5.3 Boehringer Ingelheim Parkinson’s Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Teva Pharmaceutical
8.6.1 Teva Pharmaceutical Parkinson’s Disease Drug Production Sites and Area Served
8.6.2 Teva Pharmaceutical Product Introduction, Application and Specification
8.6.3 Teva Pharmaceutical Parkinson’s Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Abbvie
8.7.1 Abbvie Parkinson’s Disease Drug Production Sites and Area Served
8.7.2 Abbvie Product Introduction, Application and Specification
8.7.3 Abbvie Parkinson’s Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Kyowa Hakko Kirin Pharma
8.8.1 Kyowa Hakko Kirin Pharma Parkinson’s Disease Drug Production Sites and Area Served
8.8.2 Kyowa Hakko Kirin Pharma Product Introduction, Application and Specification
8.8.3 Kyowa Hakko Kirin Pharma Parkinson’s Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Astellas Pharma
8.9.1 Astellas Pharma Parkinson’s Disease Drug Production Sites and Area Served
8.9.2 Astellas Pharma Product Introduction, Application and Specification
8.9.3 Astellas Pharma Parkinson’s Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Desitin Arzneimittel
8.10.1 Desitin Arzneimittel Parkinson’s Disease Drug Production Sites and Area Served
8.10.2 Desitin Arzneimittel Product Introduction, Application and Specification
8.10.3 Desitin Arzneimittel Parkinson’s Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Endo Pharmaceuticals
8.12 F.Hoffmann-La Roche
8.13 H.Lundbeck
8.14 Valeant
8.15 Apokyn
8.16 Orion
8.17 Stada Arzneimittel
8.18 US WorldMeds
8.19 Valeant Pharmaceuticals

9 Development Trend of Analysis of Parkinson’s Disease Drug Market
9.1 Global Parkinson’s Disease Drug Market Trend Analysis
9.1.1 Global Parkinson’s Disease Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Parkinson’s Disease Drug Regional Market Trend
9.2.1 North America Parkinson’s Disease Drug Forecast 2019-2025
9.2.2 Europe Parkinson’s Disease Drug Forecast 2019-2025
9.2.3 China Parkinson’s Disease Drug Forecast 2019-2025
9.2.4 Japan Parkinson’s Disease Drug Forecast 2019-2025
9.2.5 Southeast Asia Parkinson’s Disease Drug Forecast 2019-2025
9.2.6 India Parkinson’s Disease Drug Forecast 2019-2025
9.3 Parkinson’s Disease Drug Market Trend (Product Type)
9.4 Parkinson’s Disease Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Parkinson’s Disease Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Parkinson's Disease Drug
Table Global Parkinson's Disease Drug Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Parkinson's Disease Drug Production Market Share by Types in 2018
Figure Sinemet-CR Product Picture
Figure Trastal Product Picture
Figure Madopar Product Picture
Figure COMT Inhibitor Product Picture
Figure Other Product Picture
Table Global Parkinson's Disease Drug Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Parkinson's Disease Drug Consumption Market Share by Applications in 2018
Figure Under 40 Years Old
Figure 40-65 Years Old
Figure Above 65 Years Old
Figure Global Parkinson's Disease Drug Revenue (Million USD) (2014-2025)
Figure Global Parkinson's Disease Drug Production (K Units) (2014-2025)
Figure North America Parkinson's Disease Drug Market Size (Million USD) (2014-2025)
Figure Europe Parkinson's Disease Drug Market Size (Million USD) (2014-2025)
Figure China Parkinson's Disease Drug Market Size (Million USD) (2014-2025)
Figure Japan Parkinson's Disease Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Parkinson's Disease Drug Market Size (Million USD) (2014-2025)
Figure India Parkinson's Disease Drug Market Size (Million USD) (2014-2025)
Table Parkinson's Disease Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Parkinson's Disease Drug in 2018
Figure Manufacturing Process Analysis of Parkinson's Disease Drug
Figure Industry Chain Structure of Parkinson's Disease Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Parkinson's Disease Drug Manufacturing Plants Distribution
Table Parkinson's Disease Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Parkinson's Disease Drug Capacity (K Units) of Major Manufacturers (2014-2019)
Table Parkinson's Disease Drug Production (K Units) of Major Manufacturers (2014-2019)
Table Parkinson's Disease Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Parkinson's Disease Drug Production Share by Manufacturers in 2018
Table Parkinson's Disease Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Parkinson's Disease Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Parkinson's Disease Drug Revenue Share by Manufacturers in 2018
Table Parkinson's Disease Drug Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Parkinson's Disease Drug Production by Regions 2014-2019 (K Units)
Table Global Parkinson's Disease Drug Production Market Share by Regions 2014-2019
Figure Global Parkinson's Disease Drug Production Market Share by Regions in 2018
Table Global Parkinson's Disease Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Parkinson's Disease Drug Revenue Market Share by Regions 2014-2019
Figure Global Parkinson's Disease Drug Revenue Market Share by Regions in 2018
Table Global Parkinson's Disease Drug Consumption by Regions 2014-2019 (K Units)
Table Global Parkinson's Disease Drug Consumption Market Share by Regions 2014-2019
Figure North America Parkinson's Disease Drug Production Growth Rate 2014-2019 (K Units)
Figure North America Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Parkinson's Disease Drug Production, Consumption Import and Export (K Units)
Figure Europe Parkinson's Disease Drug Production Growth Rate 2014-2019 (K Units)
Figure Europe Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Parkinson's Disease Drug Production, Consumption Import and Export (K Units)
Figure China Parkinson's Disease Drug Production Growth Rate 2014-2019 (K Units)
Figure China Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Parkinson's Disease Drug Production, Consumption Import and Export (K Units)
Figure Japan Parkinson's Disease Drug Production Growth Rate 2014-2019 (K Units)
Figure Japan Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Parkinson's Disease Drug Production, Consumption Import and Export (K Units)
Figure Southeast Asia Parkinson's Disease Drug Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Parkinson's Disease Drug Production, Consumption Import and Export (K Units)
Figure India Parkinson's Disease Drug Production Growth Rate 2014-2019 (K Units)
Figure India Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Parkinson's Disease Drug Production, Consumption Import and Export (K Units)
Figure Global Consumption Parkinson's Disease Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Parkinson's Disease Drug Market Share by Application (2014-2019)
Table Merck Parkinson's Disease Drug Production Sites and Area Served
Table Merck Parkinson's Disease Drug Product Introduction, Application and Specification
Table Merck Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Parkinson's Disease Drug Production Growth Rate (2014-2019)
Table Merck Parkinson's Disease Drug Production Market Share (2014-2019)
Figure Merck Parkinson's Disease Drug Revenue Market Share (2014-2019)
Table Merck Parkinson's Disease Drug Main Business and Markets Served
Table Akorn Parkinson's Disease Drug Production Sites and Area Served
Table Akorn Parkinson's Disease Drug Product Introduction, Application and Specification
Table Akorn Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Akorn Parkinson's Disease Drug Production Growth Rate (2014-2019)
Table Akorn Parkinson's Disease Drug Production Market Share (2014-2019)
Figure Akorn Parkinson's Disease Drug Revenue Market Share (2014-2019)
Table Akorn Parkinson's Disease Drug Main Business and Markets Served
Table GSK Parkinson's Disease Drug Production Sites and Area Served
Table GSK Parkinson's Disease Drug Product Introduction, Application and Specification
Table GSK Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GSK Parkinson's Disease Drug Production Growth Rate (2014-2019)
Table GSK Parkinson's Disease Drug Production Market Share (2014-2019)
Figure GSK Parkinson's Disease Drug Revenue Market Share (2014-2019)
Table GSK Parkinson's Disease Drug Main Business and Markets Served
Table Novartis Parkinson's Disease Drug Production Sites and Area Served
Table Novartis Parkinson's Disease Drug Product Introduction, Application and Specification
Table Novartis Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Parkinson's Disease Drug Production Growth Rate (2014-2019)
Table Novartis Parkinson's Disease Drug Production Market Share (2014-2019)
Figure Novartis Parkinson's Disease Drug Revenue Market Share (2014-2019)
Table Novartis Parkinson's Disease Drug Main Business and Markets Served
Table Boehringer Ingelheim Parkinson's Disease Drug Production Sites and Area Served
Table Boehringer Ingelheim Parkinson's Disease Drug Product Introduction, Application and Specification
Table Boehringer Ingelheim Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Parkinson's Disease Drug Production Growth Rate (2014-2019)
Table Boehringer Ingelheim Parkinson's Disease Drug Production Market Share (2014-2019)
Figure Boehringer Ingelheim Parkinson's Disease Drug Revenue Market Share (2014-2019)
Table Boehringer Ingelheim Parkinson's Disease Drug Main Business and Markets Served
Table Teva Pharmaceutical Parkinson's Disease Drug Production Sites and Area Served
Table Teva Pharmaceutical Parkinson's Disease Drug Product Introduction, Application and Specification
Table Teva Pharmaceutical Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Parkinson's Disease Drug Production Growth Rate (2014-2019)
Table Teva Pharmaceutical Parkinson's Disease Drug Production Market Share (2014-2019)
Figure Teva Pharmaceutical Parkinson's Disease Drug Revenue Market Share (2014-2019)
Table Teva Pharmaceutical Parkinson's Disease Drug Main Business and Markets Served
Table Abbvie Parkinson's Disease Drug Production Sites and Area Served
Table Abbvie Parkinson's Disease Drug Product Introduction, Application and Specification
Table Abbvie Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbvie Parkinson's Disease Drug Production Growth Rate (2014-2019)
Table Abbvie Parkinson's Disease Drug Production Market Share (2014-2019)
Figure Abbvie Parkinson's Disease Drug Revenue Market Share (2014-2019)
Table Abbvie Parkinson's Disease Drug Main Business and Markets Served
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Production Sites and Area Served
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Product Introduction, Application and Specification
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Production Growth Rate (2014-2019)
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Production Market Share (2014-2019)
Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Revenue Market Share (2014-2019)
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Main Business and Markets Served
Table Astellas Pharma Parkinson's Disease Drug Production Sites and Area Served
Table Astellas Pharma Parkinson's Disease Drug Product Introduction, Application and Specification
Table Astellas Pharma Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Astellas Pharma Parkinson's Disease Drug Production Growth Rate (2014-2019)
Table Astellas Pharma Parkinson's Disease Drug Production Market Share (2014-2019)
Figure Astellas Pharma Parkinson's Disease Drug Revenue Market Share (2014-2019)
Table Astellas Pharma Parkinson's Disease Drug Main Business and Markets Served
Table Desitin Arzneimittel Parkinson's Disease Drug Production Sites and Area Served
Table Desitin Arzneimittel Parkinson's Disease Drug Product Introduction, Application and Specification
Table Desitin Arzneimittel Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Desitin Arzneimittel Parkinson's Disease Drug Production Growth Rate (2014-2019)
Table Desitin Arzneimittel Parkinson's Disease Drug Production Market Share (2014-2019)
Figure Desitin Arzneimittel Parkinson's Disease Drug Revenue Market Share (2014-2019)
Table Desitin Arzneimittel Parkinson's Disease Drug Main Business and Markets Served
Table Endo Pharmaceuticals Parkinson's Disease Drug Production Sites and Area Served
Table F.Hoffmann-La Roche Parkinson's Disease Drug Production Sites and Area Served
Table H.Lundbeck Parkinson's Disease Drug Production Sites and Area Served
Table Valeant Parkinson's Disease Drug Production Sites and Area Served
Table Apokyn Parkinson's Disease Drug Production Sites and Area Served
Table Orion Parkinson's Disease Drug Production Sites and Area Served
Table Stada Arzneimittel Parkinson's Disease Drug Production Sites and Area Served
Table US WorldMeds Parkinson's Disease Drug Production Sites and Area Served
Table Valeant Pharmaceuticals Parkinson's Disease Drug Production Sites and Area Served
Figure Global Parkinson's Disease Drug Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Parkinson's Disease Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Parkinson's Disease Drug Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Parkinson's Disease Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Parkinson's Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Parkinson's Disease Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Parkinson's Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Parkinson's Disease Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Parkinson's Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Parkinson's Disease Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Parkinson's Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Parkinson's Disease Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Parkinson's Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Parkinson's Disease Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Parkinson's Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Parkinson's Disease Drug by Type (2019-2025)
Table Global Consumption (K Units) of Parkinson's Disease Drug by Application (2019-2025)
Table Parkinson's Disease Drug Distributors List
Table Parkinson's Disease Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Merck、Akorn、GSK、Novartis、Boehringer Ingelheim、Teva Pharmaceutical、Abbvie、Kyowa Hakko Kirin Pharma、Astellas Pharma、Desitin Arzneimittel、Endo Pharmaceuticals、F.Hoffmann-La Roche、H.Lundbeck、Valeant、Apokyn、Orion、Stada Arzneimittel、US WorldMeds、Valeant Pharmaceuticals、

★調査レポート[世界のパーキンソン病薬市場 2019年] (コード：DATA909X12634)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のパーキンソン病薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のクローン病薬市場 2019年
    DATA909X06111 / QYResearch / 2019年11月15日 / ※本調査レポートは、クローン病薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アミノサリチル酸（5-ASA）、コルチコステロイド、免疫調節薬、抗生物質に、用途別には、寛解の達成（症状の欠如）、寛解の維持（再燃の予防）、小児クローン病にセグメント区分し、クローン病薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・クローン病薬の世界市場概要 ・クローン病薬の製造コスト構成分析 ・クローン病薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・クローン病薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・クローン病薬のセグメント分析（種類別） （アミノサリチル酸（5-ASA）、コルチコステロイド、免疫調節薬、抗生物質）...The global Crohn’s Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Crohn’s Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Crohn’s Disease Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Crohn’s Disease Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のデビック病薬市場 2019年
    DATA909X06374 / QYResearch / 2019年11月15日 / ※本調査レポートは、デビック病薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、グルココルチコイド、免疫グロブリン、その他に、用途別には、病院、診療所、その他にセグメント区分し、デビック病薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・デビック病薬の世界市場概要 ・デビック病薬の製造コスト構成分析 ・デビック病薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・デビック病薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・デビック病薬のセグメント分析（種類別） （グルココルチコイド、免疫グロブリン、その他）...The global Devic's Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Devic's Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Devic's Disease Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Devic's Disease Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の胃食道逆流症（GERD）薬市場 2019年
    DATA909X08375 / QYResearch / 2019年11月15日 / ※本調査レポートは、胃食道逆流症（GERD）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、H2受容体拮抗薬、プロトンポンプ阻害薬（PPi）、制酸薬に、用途別には、病院、診療所、医療センター、その他にセグメント区分し、胃食道逆流症（GERD）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・胃食道逆流症（GERD）薬の世界市場概要 ・胃食道逆流症（GERD）薬の製造コスト構成分析 ・胃食道逆流症（GERD）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・胃食道逆流症（GERD）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・胃食道逆流症（GERD）薬のセグメント分析（種類別） （H2受容体拮抗薬、プロトンポンプ阻害薬（PPi）、制酸薬）...The global Gastro Esophageal Reflux Disease (GERD) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Gastro Esophageal Reflux Disease (GERD) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gastro Esophageal Reflux Disease (GERD) Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Gastro Esophageal Reflux Disease (GERD) Drug in North America, Europe, China,...
  • 世界のシャーガス病薬市場 2019年
    DATA909X05349 / QYResearch / 2019年11月15日 / ※本調査レポートは、シャーガス病薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、Cz-007、Cz-008、D-121、DNDI-0690、EPLBS-1246、EPLBS-967、その他に、用途別には、病院、診療所、その他にセグメント区分し、シャーガス病薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・シャーガス病薬の世界市場概要 ・シャーガス病薬の製造コスト構成分析 ・シャーガス病薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・シャーガス病薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・シャーガス病薬のセグメント分析（種類別） （Cz-007、Cz-008、D-121、DNDI-0690、EPLBS-1246、EPLBS-967、その他）...The global Chagas Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Chagas Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Chagas Disease Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Chagas Disease Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のセリアック病治療薬市場 2019年
    DATA909X05241 / QYResearch / 2019年11月15日 / ※本調査レポートは、セリアック病治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、膨満感、下痢、食欲不振、その他に、用途別には、治療の第一線、治療の第二線にセグメント区分し、セリアック病治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・セリアック病治療薬の世界市場概要 ・セリアック病治療薬の製造コスト構成分析 ・セリアック病治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・セリアック病治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・セリアック病治療薬のセグメント分析（種類別） （膨満感、下痢、食欲不振、その他）...The global Celiac Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Celiac Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Celiac Disease Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Celiac Disease Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の鎌状赤血球症薬市場 2019年
    DATA909X15027 / QYResearch / 2019年11月20日 / ※本調査レポートは、鎌状赤血球症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ARQ-092、BIVV-003、CAL-H、CTX-001、DRX-194、その他に、用途別には、病院、診療所、その他にセグメント区分し、鎌状赤血球症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・鎌状赤血球症薬の世界市場概要 ・鎌状赤血球症薬の製造コスト構成分析 ・鎌状赤血球症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・鎌状赤血球症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・鎌状赤血球症薬のセグメント分析（種類別） （ARQ-092、BIVV-003、CAL-H、CTX-001、DRX-194、その他）...The global Sickle Cell Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Sickle Cell Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Sickle Cell Disease Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Sickle Cell Disease Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の胃食道逆流症治療薬及び装置市場 2019年
    DATA909X08376 / QYResearch / 2019年11月15日 / ※本調査レポートは、胃食道逆流症治療薬及び装置の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、Medigus超音波手術用エンドステープラー、LINX管理システム、Stretta療法、Bravo逆流試験システム、Digitrapper逆流試験システム、その他に、用途別には、病院、診療所、その他にセグメント区分し、胃食道逆流症治療薬及び装置の世界市場を分析しました。 ・エグゼクティブ・サマリー ・胃食道逆流症治療薬及び装置の世界市場概要 ・胃食道逆流症治療薬及び装置の製造コスト構成分析 ・胃食道逆流症治療薬及び装置の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・胃食道逆流症治療薬及び装置の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・胃食道逆流症治療薬及び装置のセグメント分析（種類別） （Medigus超音波手術用エンドステープラー、LINX管理システム、Stretta療法、Bravo逆流試験システム、Digitrapper逆流試験システム、その他）...The global Gastro Esophageal Reflux Disease Drug and Devices market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Gastro Esophageal Reflux Disease Drug and Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gastro Esophageal Reflux Disease Drug and Devices market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Gastro Esophageal Reflux Disease Drug and Devices in...
  • 世界の併用療法薬市場 2019年
    DATA909X05664 / QYResearch / 2019年11月15日 / ※本調査レポートは、併用療法薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、グリチルリチン酸二アンモニウム、インターフェロンおよびヌクレオシド薬、標的療法薬、その他に、用途別には、がん、心血管疾患、免疫疾患にセグメント区分し、併用療法薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・併用療法薬の世界市場概要 ・併用療法薬の製造コスト構成分析 ・併用療法薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・併用療法薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・併用療法薬のセグメント分析（種類別） （グリチルリチン酸二アンモニウム、インターフェロンおよびヌクレオシド薬、標的療法薬、その他）...The global Combination Therapy Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Combination Therapy Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Combination Therapy Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Combination Therapy Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆